Keyphrases
Adolescent Depression
14%
Adolescent Major Depressive Disorder
18%
Adolescents with Depression
15%
Amygdala
22%
Bipolar Disorder
12%
Borderline Personality Disorder
18%
Brain Regions
12%
Clinical Improvement
17%
Cortical Thickness
15%
Depressed Adolescents
16%
Depressive Symptoms
22%
Diffusion Tensor Imaging
8%
Dorsal Anterior Cingulate Cortex (dACC)
12%
Early Intervention
14%
Fractional Anisotropy
11%
Fronto-limbic
12%
Functional Connectivity
10%
Functional Magnetic Resonance Imaging
19%
Healthy Controls
19%
HF-rTMS
9%
HPA Axis
11%
Insula
8%
Interpersonal Psychotherapy
9%
Ketamine
14%
Major Depressive Disorder
90%
Mega-analysis
9%
Mood Disorders
15%
N-acetylcysteine
9%
Neural Correlates
20%
Neurobiology
16%
Neuroscience Research
9%
Non-suicidal Self-injury
70%
Obsessive-compulsive Disorder
22%
Older Adults
21%
Posttraumatic Stress Disorder
9%
Psychiatric Disorders
13%
Psychopathology
13%
Resting State
16%
Resting-state Functional Connectivity (rs-FC)
37%
Resting-state Functional Magnetic Resonance Imaging (rs-fMRI)
32%
Schizophrenia
13%
Stress System
9%
Suicidal Behavior
9%
Suicidal Ideation
24%
Suicidality
9%
Suicide
9%
Treatment Response
12%
Treatment-resistant Depression
20%
United States
9%
White Matter Microstructure
15%
Neuroscience
Acetylcysteine
6%
Adolescent Depression
15%
Amygdala
34%
Anterior Cingulate Cortex
15%
Antidepressant
19%
Attention Deficit Hyperactivity Disorder
5%
Automutilation
32%
Behavior (Neuroscience)
17%
Bipolar Disorder
14%
Borderline Personality Disorder
18%
Brain Development
7%
Brain Network
9%
Cortisol
11%
Depression
10%
Diffusion MRI
9%
Diffusion Tensor Imaging
8%
Face
13%
Fractional Anisotropy
12%
Frontal Lobe
5%
Functional Connectivity
21%
Functional Magnetic Resonance Imaging
39%
Gene Expression
7%
Hippocampus
8%
Hypothalamic-Pituitary-Adrenal Axis
7%
Inflammasome
6%
Ketamine
15%
Limbic System
6%
Major Depressive Disorder
100%
Meta-Analysis
7%
Mood Disorder
15%
Neurobiology
11%
Obsessive-Compulsive Disorder
11%
Orbitofrontal Cortex
7%
Pediatric Obsessive Compulsive Disorder
5%
Placebo
6%
Posttraumatic Stress Disorder
9%
Precuneus
7%
Putamen
5%
Resting-State Functional Connectivity
39%
Selective Serotonin Reuptake Inhibitor
6%
Transcranial Magnetic Stimulation
9%
Treatment-Resistant Depression
17%